1.Focus on the conceptual change of pancreatic neoplasms.
Chinese Journal of Pathology 2013;42(6):361-362
4.Try our best to learn, to face the new chellange.
Chinese Journal of Pathology 2008;37(7):433-433
6.Facing difficulties, marching to future.
Chinese Journal of Pathology 2006;35(11):642-643
Animals
;
Forecasting
;
Gene Expression Profiling
;
methods
;
Humans
;
Neoplasms
;
genetics
;
metabolism
;
pathology
;
Pathology
;
education
;
methods
;
trends
;
Proteomics
;
methods
7.Clinicopathologic study of paraganglioma.
Chinese Journal of Pathology 2006;35(8):494-496
8.Tasks and challenges.
Chinese Journal of Pathology 2010;39(4):217-217
9.Introduction of Revised philology (second edition)
Chinese Journal of Medical Library and Information Science 2016;25(9):77-80
Described in this paper are the source, significance, feasibility and expression, target, guiding ideas, organization and implementation, and achievements of the Revised philology project.
10.Clinical Effect of Low Dose Tetraiodothyronine in Hepatic Fibrosis Activity on Compensated Cirrhosis with T3 Degraded
Chinese Journal of Primary Medicine and Pharmacy 2009;16(11):1990-1991
Objectives To investigate change of Tetraiodothyronine(TH)in serum on compensated cirrhosis with T_3 degraded and observe the effect of TH in hepatic fibrosis activity.Methods Sixty patients were randomly divided into experimental group and control group.The patients in experimental group and control group received same treatment,including protecting hepatic function and nutritional support.TH were taken to experimental group with 25 mg/d for a month.clinical effect were estimated,Hepatic function and hepatic fibrosis activity were measured in serum on all patients when the treatment was over.Results In comparison with control group,the levels of AST、ALT、HA、LN、PC-Ⅲand C-Ⅳin serum were lower,the level of ALB Was indiscriminate,and proportionality of A/G was higher in cirrhosis.Clinical effect was same in two groups.Conclusion The level of TH in serum was decreasing in compensation cirrhosis,and additional TH can decrease hepatic fibrosis activity,but can not improve clinical effect in short.